Treatment of viral encephalitis by agents blocking alpha-VLA-4 integrin function

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060029600A1
SERIAL NO

11016386

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides methods of treating viral encephalitis in a patient. Such methods entail administering to the patient an effect amount of an agent that inhibits binding of leukocytes to brain endothelial cells via leukocyte surface antigen alpha-4 integrin. Such agents include antibodies and small molecules that specially bind to alpha-4 integrin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOGEN IDEC INTERNATIONAL HOLDING LTDCANON'S COURT 22 VICTORIA STREET HAMILTON HM EX

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carbone, Kathryn M Adams Town, MD 1 3
Rubin, Steven A Frederick, MD 12 130
Yednock, Theodore A Forest Knolls, CA 27 348

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation